John Canepa

2020

In 2020, John Canepa earned a total compensation of $1.3M as Chief Financial Officer at Candel Therapeutics.

Compensation breakdown

Bonus$75,000
Option Awards$1,230,085
Salary$14,231
Total$1,319,316

Canepa received $1.2M in option awards, accounting for 93% of the total pay in 2020.

Canepa also received $75K in bonus and $14.2K in salary.

Rankings

In 2020, John Canepa's compensation ranked 7,405th out of 13,090 executives tracked by ExecPay. In other words, Canepa earned more than 43.4% of executives.

ClassificationRankingPercentile
All
7,405
out of 13,090
43rd
Division
Manufacturing
3,103
out of 5,618
45th
Major group
Chemicals And Allied Products
1,251
out of 2,251
44th
Industry group
Drugs
1,080
out of 1,951
45th
Industry
Biological Products, Except Diagnostic Substances
255
out of 411
38th
Source: SEC filing on September 2, 2022.

Canepa's colleagues

We found two more compensation records of executives who worked with John Canepa at Candel Therapeutics in 2020.

2020

Paul FMedSci

Candel Therapeutics

Chief Executive Officer

2020

Estuardo inf

Candel Therapeutics

Chief Executive Officer

News

In-depth

You may also like